Strongbridge Biopharma adds Jeffrey Sherman to board of directors
Dr. Sherman has more than 25 years of research, clinical development, regulatory and commercialization experience within the biopharmaceutical industry.
Since 2009, he has served as chief medical officer and an executive vice president at Horizon Pharma.
He also previously held senior leadership positions at IDM Pharma, Takeda Global Research and Development, NeoPharm, Searle/Pharmacia, Bristol-Myers Squibb, and is a past president of the Drug Information Association (DIA).
Dr. Sherman earned his M.D. from the Rosalind Franklin University of Medicine and Science/The Chicago Medical School.
He completed internship and residency programs at Northwestern University Feinberg School of Medicine, where he currently serves as an adjunct assistant professor, and a fellowship position at the University of California San Francisco.
He received a B.A. in Biology from Lake Forest College. ■
LATEST MOVES FROM Ireland
- Cairn Homes appoints Timothy Kenny as CFO
- C&C Group appoints Jim Clerkin as director
- Permanent TSB Group names Robert Elliott as chairman
- Bank of Ireland CEO Richie Boucher to step down
- Kenmare Resources appoints Peter Bacchus to board
More inside POST
Things successful leaders did only once Leadership